Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Abril, N.
Right arrow Articles by Pueyo, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abril, N.
Right arrow Articles by Pueyo, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 20, No. 11, 2089-2094, November 1999
© 1999 Oxford University Press


Cancer Biology

Human O6-alkylguanine-DNA alkyltransferase: protection against alkylating agents and sensitization to dibromoalkanes

Nieves Abril, Francisco L. Luque-Romero, Fred C. Christians1,2, Lance P. Encell1, Lawrence A. Loeb1 and Carmen Pueyo3

Departamento de Bioquímica y Biología Molecular, Avda. de Medina Azahara s/n, Universidad de Córdoba, 14071-Córdoba, España and
1 The Joseph Gottstein Memorial Cancer Research Laboratory, Departments of Pathology and Biochemistry, University of Washington, Seattle, WA 98195-7705, USA

O6-alkylguanine-DNA alkyltransferase (AGT) is a suicide protein that corrects DNA damage by alkylating agents and may also serve to activate environmental carcinogens. We expressed human wild-type and two active mutant AGTs in bacteria that lack endogenous AGT and are also defective in nucleotide excision repair, to examine the ability of the AGTs to protect Escherichia coli from DNA damage by different types of alkylating agents and, oppositely, to sensitize cells to the genotoxic effects of dibromoalkanes (DBAs). Control bacteria carrying the cloning vector alone were extremely sensitive to mutagenesis by low, noncytotoxic doses of N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). Expression of human wild-type AGT prevented most of this enlarged susceptibility to MNNG mutagenesis. Oppositely, cell killing required much higher MNNG concentrations and prevention by wild-type AGT was much less effective. Mutants V139F and V139F/P140R/L142M protected bacteria against MNNG-induced cytotoxicity more effectively than the wild-type AGT, but protection against the less stringent mutagenesis assay was variable. Subtle differences between wild-type AGT and the two mutant variants were further revealed by assaying protection against mutagenesis by more complex alkylating agents, such as N-ethyl-N-nitrosourea and 1-(2-chloro- ethyl)-3-cyclohexyl-1-nitrosourea. Unlike wild-type and V139F, the triple mutant variant, V139F/P140R/L142M was unaffected by the AGT inhibitor, O6-benzylguanine. Wild-type AGT and V139F potentiated the genotoxic effects of DBAs; however, the triple mutant virtually failed to sensitize the bacteria to these agents. These experiments provide evidence that in addition to the active site cysteine at position 145, the proline at position 140 might be important in defining the capacity by which AGTs modulate genotoxicity by environmentally relevant DBAs. The ability of AGTs to activate dibromoalkanes suggests that this DNA repair enzyme could be altered, and if expressed in tumors might be lethal by enhancing the activation of specific chemotherapeutic prodrugs.

Abbreviations: AGT, O6-alkylguanine-DNA alkyltransferase; BG, O6- benzylguanine; CCNU, 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea; DBAs, dibromoalkanes; DBE, 1,2-dibromoethane (or ethylene dibromide); DBM, dibromomethane; ENU, N-ethyl-N-nitrosourea; GSH, glutathione; MNNG, N-methyl-N'-nitro-N-nitrosoguanidine ; O6-alkG, O6-alkylguanine; O6-meG, O6-methylguanine.

2 Present address: Affymetrix, 3380 Central Expressway, Santa Clara, CA 95051, USA

3 To whom correspondence should be addressed Email: bb1pucuc{at}uco.es


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
L. Liu, D. L. Hachey, G. Valadez, K. M. Williams, F. P. Guengerich, N. A. Loktionova, S. Kanugula, and A. E. Pegg
Characterization of a Mutagenic DNA Adduct Formed from 1,2-Dibromoethane by O6-Alkylguanine-DNA Alkyltransferase
J. Biol. Chem., February 6, 2004; 279(6): 4250 - 4259.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. P. Margison, A. C. Povey, B. Kaina, and M. F. Santibanez Koref
Variability and regulation of O6-alkylguanine-DNA alkyltransferase
Carcinogenesis, April 1, 2003; 24(4): 625 - 635.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Liu, A. E. Pegg, K. M. Williams, and F. P. Guengerich
Paradoxical Enhancement of the Toxicity of 1,2-Dibromoethane by O6-Alkylguanine-DNA Alkyltransferase
J. Biol. Chem., September 27, 2002; 277(40): 37920 - 37928.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Y. Hong, R. S. Chapkin, J. S. Morris, N. Wang, R. J. Carroll, N. D. Turner, W. C. L. Chang, L. A. Davidson, and J. R. Lupton
Anatomical site-specific response to DNA damage is related to later tumor development in the rat azoxymethane colon carcinogenesis model
Carcinogenesis, November 1, 2001; 22(11): 1831 - 1835.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.